1. Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review

   • Irene E. van der Horst-Bruinsma
   • Philip C. Robinson
   • Atul Deodhar

   Review Open access 30 September 2022 Pages: 1481 - 1497

   

2. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren’s

   • Carl Cooper
   • Samantha Wratten
   • Pushpendra Goswami

   Original Research Open access 16 September 2022 Pages: 1499 - 1515

   

3. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials

   • Martin Bergman
   • Maya H. Buch
   • Vibeke Strand

   Original Research Open access 20 September 2022 Pages: 1517 - 1529

   

4. Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis

   • Alen Brkic
   • Katarzyna Łosińska
   • Glenn Haugeberg

   Original Research Open access 21 September 2022 Pages: 1531 - 1547

   

5. Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout

   • Aaron Broadwell
   • John A. Albert
   • Brian LaMoreaux

   Original Research Open access 22 September 2022 Pages: 1549 - 1558

   

6. Content Validity of Sjögren’s Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren’s

   • Natasha Griffiths
   • Samantha Wratten
   • Pushpendra Goswami

   Original Research Open access 24 September 2022 Pages: 1559 - 1574

   

7. Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists

   • Marta Olejárová
   • Želmíra Macejová
   • Pavel Prágr

   Original Research Open access 24 September 2022 Pages: 1575 - 1586

   

8. Population Pharmacokinetics and Exposure–Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis

   • Neha Thakre
   • Ronilda D’Cunha
   • Ahmed A. Suleiman

   Original Research Open access 30 September 2022 Pages: 1587 - 1603

   

9. Long-Term Adherence to Etanercept in Treatment Effectiveness of Patients with Spondyloarthritis: 7-Year Data from the Iraq National Registry

   • Ali Abdulrahman Younis
   • Ali Hussein Al-Hafidh
   • Ali AlJabban

   Original Research Open access 30 September 2022 Pages: 1605 - 1616